Marine bacterial gene LfliZ and use

US10351857B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10351857-B2
Application numberUS-201615765024-A
CountryUS
Kind codeB2
Filing dateOct 24, 2016
Priority dateJun 15, 2016
Publication dateJul 16, 2019
Grant dateJul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

It relates to a LfliZ gene and its application. The sequence of gene LfliZ is shown in SEQ ID NO.1. This invention also relates to the recombinant protein LfliZ encoded by LfliZ gene and its application in preparation of 2′, 3′-cNMPs. The recombinant LfliZ protein encoded by gene LfliZ can bind four kinds of 2′, 3′-cNMPs during its expression in Escherichia coli. Four kinds of 2′, 3′-cNMPs can be prepared simultaneously from the recombinant E. coli by extracting the recombinant protein LfliZ. The yield of 2′, 3′-cNMPs reaches 2.5 mg/L fermentation broth by the method in the present invention, indicating that this method has a good application potential.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant vector, containing a gene L fliZ having nucleotide sequence as shown in SEQ ID NO:1. 2. The recombinant vector according to claim 1 , wherein the recombinant vector is constructed with a plasmid pET-22b (+). 3. The recombinant vector according to claim 1 , wherein the recombination vector is transformed into a host cell yields a recombinant cell. 4. The recombinant vector according to claim 3 , wherein the host cell is E. coli. 5. The recombinant vector according to claim 4 , wherein the E. coli is E. coli BL21 (DE3). 6. A process for preparing 2′,3′-cyclic nucleoside monophosphates (2′,3′-cNMPs) by using a gene L fliZ , wherein the gene L fliZ having nucleotide sequence as shown in SEQ ID NO:1; cloning the gene L fliZ into a plasmid as a recombinant vector that is transformed into a host cell that yields as a recombinant cell; culturing the recombinant cell in a fermentation medium; then, preparing the 2′, 3′-cNMPs from the recombinant cell. 7. The process according to claim 6 , wherein the plasmid is pET-22b (+); the host cell is E. coli. 8. The process according to claim 6 , wherein the fermentation medium is LB medium. 9. A process for preparing 2′, 3′-cNMPs by using a gene L fliZ , wherein the gene L fliZ having nucleotide sequence as shown in SEQ ID NO:1; cloning the gene L fliZ into a plasmid as a recombinant vector that is transformed into a host cell that yields as a recombinant cell; culturing the recombinant cell in a fermentation medium; breaking the recombinant cells and purifying a recombinant protein L fliZ having the amino acid sequence shown as SEQ ID NO:2; incubating the recombinant protein L fliZ in a recombinant protein L fliZ solution; and preparing the 2′, 3′-cNMPs from the recombinant protein L fliZ solution. 10. The process according to claim 9 , wherein the plasmid is pET-22b (+); the host cell is E. coli. 11. The process according to claim 9 , wherein the fermentation medium is LB medium. 12. The process according to claim 9 , wherein the recombinant protein L fliZ solution is consisting of 10 mM Tris-HCl, 100 mM NaCl, pH 7.5.

Assignees

Inventors

Classifications

  • C12N15/70Primary

    Vectors or expression systems specially adapted for E. coli · CPC title

  • having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide · CPC title

  • Pyrimidine nucleotides · CPC title

  • C07K14/195Primary

    from bacteria · CPC title

  • by filtration, ultrafiltration or reverse osmosis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10351857B2 cover?
It relates to a LfliZ gene and its application. The sequence of gene LfliZ is shown in SEQ ID NO.1. This invention also relates to the recombinant protein LfliZ encoded by LfliZ gene and its application in preparation of 2′, 3′-cNMPs. The recombinant LfliZ protein encoded by gene LfliZ can bind four kinds of 2′, 3′-cNMPs during its expression in Escherichia coli. Four kinds of 2′, 3′-cNMPs can …
Who is the assignee on this patent?
Univ Shandong
What technology area does this patent fall under?
Primary CPC classification C12N15/70. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).